Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Stockwatch: Teva, Biogen, Ionis, Sage And The Art Of Strategic News Placement

Aug 08 2016

• By Andy Smith

SC1608_WomanWithMegaphone_1200x675 — • Source: Shutterstock: Sergey Nivens

Related Content

Teva’s Rosy View For A Happy Union With Allergan Generics

Jul 13 2016

Merck, Allergan Suggested As Suitors But Biogen's Attractiveness Under Question

Aug 03 2016

Rise Of The Biosimilar Formulary: CVS Excludes Lantus, Neupogen For 2017

Aug 03 2016

Filings Soon As Biogen Snaps Up Ionis' Antisense Treatment

Aug 02 2016

Related Companies

Teva Pharmaceutical Industries Ltd.

Allergan plc

Hikma Pharmaceuticals plc

CVS Health Corp.

Fresenius SE & Co. KGaA

Ionis Pharmaceuticals, Inc.

Biogen, Inc.

Merck & Co., Inc.

Sage Therapeutics, Inc.

Additional Topics

Companies M & A Strategy Commercial BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window